Yash Trading [YASTF] vs Johnson Pharmacare [JOHNPHARMA] Detailed Stock Comparison
Yash Trading
BSE
Loading...
Johnson Pharmacare
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Yash Trading wins in 9 metrics, Johnson Pharmacare wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Yash Trading | Johnson Pharmacare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 9,605.00 | -77.00 | Johnson Pharmacare |
| Price-to-Book Ratio | 8.47 | 0.71 | Johnson Pharmacare |
| Debt-to-Equity Ratio | 0.00 | 1.08 | Yash Trading |
| PEG Ratio | -58.91 | 0.77 | Yash Trading |
| EV/EBITDA | -448.65 | -104.18 | Yash Trading |
| Profit Margin (TTM) | 8.83% | 0.00% | Yash Trading |
| Operating Margin (TTM) | 25.07% | 127.68% | Johnson Pharmacare |
| EBITDA Margin (TTM) | 25.07% | 127.68% | Johnson Pharmacare |
| Return on Equity | -15.07% | -1.04% | Johnson Pharmacare |
| Return on Assets (TTM) | -14.59% | -1.01% | Johnson Pharmacare |
| Free Cash Flow (TTM) | $-12.52M | $-19.09M | Yash Trading |
| 1-Year Return | 162.73% | -27.78% | Yash Trading |
| Price-to-Sales Ratio (TTM) | 80.88 | -128.67 | Johnson Pharmacare |
| Enterprise Value | $576.07M | $429.41M | Yash Trading |
| EV/Revenue Ratio | 24.26 | -128.80 | Johnson Pharmacare |
| Gross Profit Margin (TTM) | 33.13% | N/A | N/A |
| Revenue per Share (TTM) | $17 | $0 | Yash Trading |
| Earnings per Share (Diluted) | $0.02 | $-0.01 | Yash Trading |
| Beta (Stock Volatility) | 0.25 | -0.91 | Johnson Pharmacare |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Yash Trading vs Johnson Pharmacare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Yash Trading | -1.98% | -1.98% | 10.54% | -14.62% | 115.62% | 173.29% |
| Johnson Pharmacare | 0.00% | -1.27% | -1.27% | -12.36% | -20.41% | -30.97% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Yash Trading | 162.73% | 969.89% | 969.89% | 969.89% | 969.89% | 969.89% |
| Johnson Pharmacare | -27.78% | -4.88% | -83.98% | -83.98% | -83.98% | -83.98% |
News Based Sentiment: Yash Trading vs Johnson Pharmacare
Yash Trading
News based Sentiment: POSITIVE
September was a month of important corporate housekeeping for Yash Trading & Finance Ltd., with the submission of its annual report and scheduling of the AGM. While financial ratios present a mixed picture, the stock's impressive year-to-date and one-year returns suggest continued investor confidence and growth potential.
Johnson Pharmacare
News based Sentiment: NEGATIVE
September proved to be a significantly negative month for Johnson Pharmacare Ltd., marked by a declining share price, a negative P/E ratio, and a pessimistic forecast from an AI analyst. These factors collectively paint a concerning picture for investors, highlighting the stock's high-risk profile and limited potential for near-term gains.
Performance & Financial Health Analysis: Yash Trading vs Johnson Pharmacare
| Metric | YASTF | JOHNPHARMA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.95B | ₹429.00M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 381 | 949,869 |
| 90 Day Avg. Volume | 301 | 969,400 |
| Last Close | ₹188.30 | ₹0.78 |
| 52 Week Range | ₹21.38 - ₹239.30 | ₹0.75 - ₹1.20 |
| % from 52W High | -21.31% | -35.00% |
| All-Time High | ₹239.30 (Jun 09, 2025) | ₹7.14 (Jan 03, 2022) |
| % from All-Time High | -21.31% | -89.08% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | N/A |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.09% | 0.00% |
| Operating Margin (TTM) | 0.25% | 1.28% |
| Return on Equity (TTM) | -0.15% | -0.01% |
| Debt to Equity (MRQ) | 0.00 | 1.08 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹22.67 | ₹1.09 |
| Cash per Share (MRQ) | ₹0.08 | ₹0.00 |
| Operating Cash Flow (TTM) | ₹-12,519,000 | ₹-19,089,000 |
| Levered Free Cash Flow (TTM) | ₹-2,406,000 | ₹-5,838,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Yash Trading vs Johnson Pharmacare
| Metric | YASTF | JOHNPHARMA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 9,605.00 | -77.00 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -58.91 | 0.77 |
| Price to Sales (TTM) | 80.88 | -128.67 |
| Price to Book (MRQ) | 8.47 | 0.71 |
| Market Capitalization | ||
| Market Capitalization | ₹1.95B | ₹429.00M |
| Enterprise Value | ₹576.07M | ₹429.41M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 24.26 | -128.80 |
| Enterprise to EBITDA | -448.65 | -104.18 |
| Risk & Other Metrics | ||
| Beta | 0.25 | -0.91 |
| Book Value per Share (MRQ) | ₹22.67 | ₹1.09 |
Financial Statements Comparison: Yash Trading vs Johnson Pharmacare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | YASTF | JOHNPHARMA |
|---|---|---|
| Revenue/Sales | ₹23.72M | ₹0 |
| Cost of Goods Sold | ₹15.86M | ₹0 |
| Gross Profit | ₹7.86M | ₹0 |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹5.92M | ₹-534,000 |
| EBITDA | ₹5.95M | ₹-534,000 |
| Pre-Tax Income | ₹3.99M | ₹-534,000 |
| Income Tax | ₹0 | N/A |
| Net Income (Profit) | ₹3.99M | ₹-534,000 |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | YASTF | JOHNPHARMA |
|---|---|---|
| Cash & Equivalents | ₹229,000 | ₹77,000 |
| Total Current Assets | ₹491,000 | ₹156.34M |
| Total Current Liabilities | ₹529,000 | ₹11.51M |
| Long-Term Debt | ₹0 | ₹6.05M |
| Total Shareholders Equity | ₹15.96M | ₹561.69M |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | YASTF | JOHNPHARMA |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | YASTF | JOHNPHARMA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 381 | 949,869 |
| Average Daily Volume (90 Day) | 301 | 969,400 |
| Shares Outstanding | 3.00M | 550.00M |
| Float Shares | 115,440 | 519.05M |
| % Held by Insiders | 1.06% | 0.06% |
| % Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Yash Trading vs Johnson Pharmacare
| Metric | YASTF | JOHNPHARMA |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |